Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BUX.CNthis companyBioMark Diagnostics Inc.	CA$0.45	-40.43×	180.94×	1,001.91×	-40.29×	-101.2%	-539.4%	-3130.7%	-2470.8%	-446.2%	-163.3%	-1.8%	2.19×	-0.07×	-29.59×	0.99×	0.0%	1	4.74	1	D+
ASEP.CNAsep Medical Holdings Inc	CA$0.10	-0.58×	1.24×	8.56×	-1.6×	1594.5%	-111.2%	-761.4%	-1459.7%	-211.2%	-40.6%	-35.3%	0.1×	-0.04×	-96.96×	0.12×	0.0%	4	-5.66	—	—
AVCR.VAvricore Health Inc.	CA$0.05	-2.72×	13×	9.49×	-3.94×	-985.8%	44.3%	-256.1%	-348.2%	-477.1%	-351.0%	-17.9%	0×	0.19×	-151.48×	2.11×	0.0%	2	-12.33	1	D+
IZO.CNIzotropic Corporation	CA$0.13	-9.6×	-3.74×	0×	-16.94×	-159.6%	0.0%	0.0%	0.0%	38.8%	57.4%	-4.1%	-0.55×	-2.05×	-3×	0.06×	0.0%	1	-176.57	2	C
MDMDX.VMedx Health Corp.	CA$0.05	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
SONA.CNSona Nanotech Inc.	CA$0.26	-21.45×	-1,796.66×	0×	-25.66×	-102.9%	0.0%	0.0%	0.0%	8381.9%	-1239.4%	-2.8%	-7.94×	-0.07×	-89.24×	0.28×	0.0%	2	-74.3	2	C
Peer median	—	-6.16×	-1.25×	4.28×	-10.44×	-131.2%	0.0%	-128.1%	-174.1%	-86.2%	-195.8%	-11.0%	-0.28×	-0.05×	-93.1×	0.2×	0.0%	2	-43.32	2	—